10 recent exec moves affecting the pharma industry

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.

Rockville, Md.-based biotech company Emmes named Christine Dingivan, MD, as its brand-new president and CEO.

Ipsen selected Philippe Lopes-Fernandes as its new executive vice president and chief service officer.

Vedanta Biosciences named Merck and AbbVie veteran Jeffrey Silber, MD, its brand-new CMO.

Repertoire Immune Medicines called Anthony Coyle, PhD, president of research study and development.

More short articles on drug store: Pharmacy groups blast United States importation of drugs from CanadaFDA issues warning over TikTok Benadryl challengeMilitary workers make up lions share of Operation Warp Speed leaders.

Previous Amazon executive Omer Gajial was called senior vice president of drug store and health at Albertsons, which runs 1,726 drug stores in the U.S.

Minneapolis-based drugmaker Humanetics welcomed former U.S. Surgeon General Matthew Nathan, MD, to its board of directors.

Synthetic intelligence-powered drugmaker Exscientia welcomed David Nicholson, PhD, as chair of its board of directors.

Tmunity also named Simona King as its new CFO.

Previous Agios CFO Andrew Hirsch ended up being the CEO of Watertown, Mass.-based C4 Therapeutics.

Below are 10 executive leadership changes affecting the pharmaceutical market that were revealed in September.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by click on this link.

Philadelphia-based drugmaker Tmunity called Johnson & & Johnson and GlaxoSmithKline veteran Vijay Reddy, MD, its brand-new chief research and development officer.

Katie Adams –
Tuesday, September 29th, 2020
Print|Email.